Type 2 diabetes mellitus
Not yet recruitingStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
- Disease:Type 2 diabetes mellitus
- Substances:Insulin GlarginePOLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
Bulgaria- Participants:18–64 years
- Substances:Insulin Glargine
- Sponsor:Novo Nordisk A/S



